Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 55154-7289

6 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 55154-7289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph comparing the cumulative incidence percentage over time in years for Atorvastatin versus placebo. The graph shows two lines: a solid line representing Atorvastatin and a dotted line representing placebo, with a hazard ratio (HR) of 0.64 and a p-value of 0.0005 indicated on the chart.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph showing cumulative hazard (%) over time in years (up to 5 years) for two groups: Atorvastatin and placebo. The graph compares time to first primary endpoint through four years of follow-up, with the Atorvastatin group demonstrating a lower cumulative hazard compared to placebo.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A Kaplan-Meier curve showing the time to first major cardiovascular endpoint over 5 years for subjects taking atorvastatin at 10 mg and 80 mg doses. The graph plots the percentage of subjects experiencing events over time, indicating a hazard ratio of 0.78 with statistical significance (P=0.0002).*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, illustrating the molecular composition and arrangement of atoms including the calcium ion complex.*
FDA Label Image

Bag Label (Image 01)

Bag Label (Image 01)
ATOVASTATIN CALCIUM tablets USP 40 mg film-coated oral tablets, in a package containing 10 tablets. The label includes storage instructions, dosage form, strength, warnings, and manufacturing information. Manufactured by Apotex Inc., Canada, and for Apotex Corp., Florida, with distribution by MAJOR Pharmaceuticals and Cardinal Health.*
FDA Label Image

Bag Label (Image 02)

Bag Label (Image 02)
Packaging label for Atorvastatin Calcium Tablets USP 80 mg, film-coated, by Cardinal Health 107, LLC. The label indicates a package containing 10 tablets. It includes storage instructions, dispensing requirements, and distributor information from Major Pharmaceuticals and Cardinal Health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.